Kevin Fitzgerald
Chief Tech/Sci/R&D Officer at ALNYLAM PHARMACEUTICALS, INC.
Net worth: 3 M $ as of 30/12/2024
Profile
Currently, Kevin Fitzgerald occupies the position of Chief Scientific Officer & Senior Vice President at Alnylam Pharmaceuticals, Inc. He received an undergraduate degree from Cornell University and a doctorate from Princeton University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
26/11/2024 | 13,418 ( 0.01% ) | 3 M $ | 30/12/2024 | |
OVID THERAPEUTICS INC.
-.--% | 11/12/2024 | 0 ( -.--% ) | - $ | 30/12/2024 |
Latest news about Kevin Fitzgerald
Kevin Fitzgerald active positions
Companies | Position | Start |
---|---|---|
ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 31/08/2016 |
OVID THERAPEUTICS INC. | Director/Board Member | 05/10/2021 |
Training of Kevin Fitzgerald
Cornell University | Undergraduate Degree |
Princeton University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
OVID THERAPEUTICS INC. | Health Technology |
- Stock Market
- Insiders
- Kevin Fitzgerald